Process modelling and simulation for continuous pharmaceutical manufacturing of ibuprofen

被引:59
|
作者
Jolliffe, Hikaru G. [1 ]
Gerogiorgis, Dimitrios I. [1 ]
机构
[1] Univ Edinburgh, Sch Engn, IMP, Edinburgh EH9 3JL, Midlothian, Scotland
来源
基金
英国工程与自然科学研究理事会;
关键词
Continuous Pharmaceutical; Manufacturing (CPM); Green chemistry; Process design; Process modelling; Process simulation; Ibuprofen; CONTINUOUS-FLOW SYNTHESIS; CHRONIC MYELOID-LEUKEMIA; OPIOID RECEPTOR AGONIST; ORGANIC-COMPOUNDS; LIQUID-MIXTURES; SCALE-UP; ARTEMISININ; CHEMISTRY; DESIGN; PURIFICATION;
D O I
10.1016/j.cherd.2014.12.005
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Pharmaceutical corporations face rapidly rising process research and development (R&D) as well as production costs due to globalised competition. Batch production processes are dominant in the pharmaceutical industry and have multiple advantages, including equipment flexibility, high-fidelity quality control and the ability to recall specific batches; they however suffer disadvantages such as limited heat transfer and mixing scalability and low operational asset efficiency. Continuous Pharmaceutical Manufacturing (CPM) has a documented potential to reduce cost, as continuous production techniques can be easier to scale up and can be designed to be more efficient in terms of both solvent and energy use: therefore, it is both timely and important to explore the expanding feasibility limits of this emerging technology. The literature has been extensively surveyed in order to identify a series of candidate Active Pharmaceutical Ingredients (API) for flowsheet synthesis, process modelling and mass balance simulation toward rapid assessment of CPM potential. Ibuprofen [2-(4-isobutylphenyl)propanoic acid], the widely used non-steroidal anti-inflammatory drug (NSAID), has emerged as an ideal CPM candidate because it is in high global demand and can generate significant profit margins. The flowsheet is based on a published organic synthesis pathway and produces 50 kg of ibuprofen annually using three plug flow reactors (PFRs) in series, followed by a final separation for purification. Kinetic and thermodynamic parameter estimation modelling has been employed in order to compute essential data for design, and all PFR reactors have been designed based on reported conversions of feed and intermediate organic molecules in the respective organic synthesis reactions. Theoretically computed reactor designs are in good agreement with experimental prototypes constructed for the same organic synthesis, as well as in with previously reported CPM systems. The developed continuous final separation performs very well in accordance with green chemistry principles, with relatively low environmental impact (E-factor = 25.4). (C) 2014 The Institution of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:175 / 191
页数:17
相关论文
共 50 条
  • [1] Process modelling and simulation for continuous pharmaceutical manufacturing of artemisinin
    Jolliffe, Hikaru G.
    Gerogiorgis, Dimitrios I.
    [J]. CHEMICAL ENGINEERING RESEARCH & DESIGN, 2016, 112 : 310 - 325
  • [2] Process modelling, simulation and technoeconomic optimisation for continuous pharmaceutical manufacturing of (S)-warfarin
    Diab, Samir
    Gerogiorgis, Dimitrios I.
    [J]. 28TH EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING, 2018, 43 : 1643 - 1648
  • [3] Process modelling, simulation and technoeconomic evaluation of crystallisation antisolvents for the continuous pharmaceutical manufacturing of rufinamide
    Diab, Samir
    Gerogiorgis, Dimitrios I.
    [J]. COMPUTERS & CHEMICAL ENGINEERING, 2018, 111 : 102 - 114
  • [4] Continuous Manufacturing in Pharmaceutical Process Development and Manufacturing
    Burcham, Christopher L.
    Florence, Alastair J.
    Johnson, Martin D.
    [J]. ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 9, 2018, 9 : 253 - 281
  • [5] Modelling and simulation of manufacturing process chains
    Afazov, S. M.
    [J]. CIRP JOURNAL OF MANUFACTURING SCIENCE AND TECHNOLOGY, 2013, 6 (01) : 70 - 77
  • [6] Business Process Model of Continuous Improvement in Pharmaceutical Manufacturing
    Sugiyama, Hirokazu
    Schmidt, Rainer
    [J]. KAGAKU KOGAKU RONBUNSHU, 2014, 40 (03) : 201 - 210
  • [7] Intelligent Process Management for Continuous Operations in Pharmaceutical Manufacturing
    Giridhar, Arun
    Gupta, Anshu
    Louvier, Matt
    Joglekar, Girish
    Nagy, Zoltan K.
    Reklaitis, Gintaras V.
    [J]. 24TH EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING, PTS A AND B, 2014, 33 : 391 - 396
  • [8] Process Modeling, Simulation, and Technoeconomic Evaluation of Separation Solvents for the Continuous Pharmaceutical Manufacturing (CPM) of Diphenhydramine
    Diab, Samir
    Gerogiorgis, Dimitrios I.
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2017, 21 (07) : 924 - 946
  • [9] Continuous Pharmaceutical Manufacturing
    Korhonen, Ossi
    [J]. PHARMACEUTICS, 2020, 12 (10)
  • [10] Multi-scale flowsheet simulation of an integrated continuous purification-downstream pharmaceutical manufacturing process
    Sen, Maitraye
    Chaudhury, Anwesha
    Singh, Ravendra
    John, Joyce
    Ramachandran, Rohit
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 445 (1-2) : 29 - 38